Literature DB >> 25399322

Inhibitory Effects of JEUD-38, a New Sesquiterpene Lactone from Inula japonica Thunb, on LPS-Induced iNOS Expression in RAW264.7 Cells.

Xiaoqing Wang1, Sheng-An Tang, Ran Wang, Yuling Qiu, Meihua Jin, Dexin Kong.   

Abstract

We isolated JEUD-38, a new sesquiterpene lactone from Inula japonica Thunb. JEUD-38 dramatically attenuated lipopolysaccharide (LPS)-induced nitric oxide (NO) production. Consistent with this finding, the protein expression of inducible nitric oxide synthase (iNOS) was blocked by JEUD-38 in a concentration-dependent manner. To elucidate the mechanism, we examined the effect of JEUD-38 on LPS-stimulated nuclear factor-κB (NF-κB) nuclear translocation, inhibitory factor-κB (IκB) phosphorylation, and degradation. JEUD-38 reduced the translocation of p65, via abrogating IκB-α phosphorylation and degradation. In addition, JEUD-38 inhibited LPS-stimulated phosphorylation of mitogen-activated protein kinases (MAPKs) including extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), and p38. Since iNOS as well as the upstream NF-κB and MAPKs are known to be closely involved in inflammation, these results suggest that JEUD-38 is a promising candidate for prevention and therapy of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25399322     DOI: 10.1007/s10753-014-0056-2

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  36 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Inula japonica extract inhibits mast cell-mediated allergic reaction and mast cell activation.

Authors:  Yue Lu; Ying Li; Meihua Jin; Ju Hye Yang; Xian Li; Guang Hsuan Chao; Hyo-Hyun Park; Young Na Park; Jong Keun Son; Eunkyung Lee; Hyeun Wook Chang
Journal:  J Ethnopharmacol       Date:  2012-06-21       Impact factor: 4.360

Review 3.  Compartmentalised MAPK pathways.

Authors:  M D Brown; D B Sacks
Journal:  Handb Exp Pharmacol       Date:  2008

Review 4.  IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

Authors:  Jun-Li Luo; Hideaki Kamata; Michael Karin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 5.  Impact of inflammation on vascular disease in hypertension.

Authors:  Agostino Virdis; Umberto Dell'Agnello; Stefano Taddei
Journal:  Maturitas       Date:  2014-04-24       Impact factor: 4.342

6.  Anti-diabetic and hypolipidemic effects of aqueous-extract from the flower of Inula japonica in alloxan-induced diabetic mice.

Authors:  Jun-Jie Shan; Ming Yang; Jin-Wei Ren
Journal:  Biol Pharm Bull       Date:  2006-03       Impact factor: 2.233

7.  IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line.

Authors:  E D Chan; D W Riches
Journal:  Am J Physiol Cell Physiol       Date:  2001-03       Impact factor: 4.249

Review 8.  Nitric oxide: new evidence for novel therapeutic indications.

Authors:  Sunil J Wimalawansa
Journal:  Expert Opin Pharmacother       Date:  2008-08       Impact factor: 3.889

Review 9.  NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases.

Authors:  X-F Sun; H Zhang
Journal:  Histol Histopathol       Date:  2007-12       Impact factor: 2.303

10.  Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-gamma, TGF-beta, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages.

Authors:  S E Chesrown; J Monnier; G Visner; H S Nick
Journal:  Biochem Biophys Res Commun       Date:  1994-04-15       Impact factor: 3.575

View more
  8 in total

1.  1-O-Actylbritannilactone Ameliorates Alcohol-Induced Hepatotoxicity through Regulation of ROS/Akt/NF-κB-Mediated Apoptosis and Inflammation.

Authors:  Li-Ya Xie; Zhen Yang; Ying Wang; Jun-Nan Hu; Ya-Wei Lu; Hao Zhang; Shuang Jiang; Wei Li
Journal:  ACS Omega       Date:  2022-05-16

2.  Cudraflavanone B Isolated from the Root Bark of Cudrania tricuspidata Alleviates Lipopolysaccharide-Induced Inflammatory Responses by Downregulating NF-κB and ERK MAPK Signaling Pathways in RAW264.7 Macrophages and BV2 Microglia.

Authors:  Wonmin Ko; Kwan-Woo Kim; Tran Hong Quang; Chi-Su Yoon; Nayeon Kim; Hwan Lee; Sam-Cheol Kim; Eun-Rhan Woo; Youn-Chul Kim; Hyuncheol Oh; Dong-Sung Lee
Journal:  Inflammation       Date:  2021-02       Impact factor: 4.092

Review 3.  Role of Antioxidants and Natural Products in Inflammation.

Authors:  Palanisamy Arulselvan; Masoumeh Tangestani Fard; Woan Sean Tan; Sivapragasam Gothai; Sharida Fakurazi; Mohd Esa Norhaizan; S Suresh Kumar
Journal:  Oxid Med Cell Longev       Date:  2016-10-10       Impact factor: 6.543

4.  Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells.

Authors:  Qianxiang Zhou; Yali Chen; Lei Zhang; Yuxu Zhong; Zhe Zhang; Ran Wang; Meihua Jin; Min Gong; Yuling Qiu; Dexin Kong
Journal:  Oncotarget       Date:  2017-06-13

Review 5.  The Complexity of Sesquiterpene Chemistry Dictates Its Pleiotropic Biologic Effects on Inflammation.

Authors:  Narcy Arizmendi; Syed Benazir Alam; Khalid Azyat; Darren Makeiff; A Dean Befus; Marianna Kulka
Journal:  Molecules       Date:  2022-04-11       Impact factor: 4.927

6.  In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells.

Authors:  Qianxiang Zhou; Yali Chen; Xi Chen; Wennan Zhao; Yuxu Zhong; Ran Wang; Meihua Jin; Yuling Qiu; Dexin Kong
Journal:  Int J Biol Sci       Date:  2016-04-08       Impact factor: 6.580

7.  Spinacetin Suppresses the Mast Cell Activation and Passive Cutaneous Anaphylaxis in Mouse Model.

Authors:  Ning Ji; Shunli Pan; Chen Shao; Yufen Chen; Zhe Zhang; Ran Wang; Yuling Qiu; Meihua Jin; Dexin Kong
Journal:  Front Pharmacol       Date:  2018-07-30       Impact factor: 5.810

Review 8.  Sesquiterpene Lactones: Promising Natural Compounds to Fight Inflammation.

Authors:  Melanie S Matos; José D Anastácio; Cláudia Nunes Dos Santos
Journal:  Pharmaceutics       Date:  2021-06-30       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.